Mono Pharmacare Ltd
Mono Pharmacare Ltd Live Price Chart
Performance
| Previous Close | ₹ 9 |
| High | ₹ 9 |
| Volume | 2000 |
| 52W Range | ₹ 7.5 - ₹ 25.5 |
| Open | ₹ 8.55 |
| Low | ₹ 8.55 |
| Market Cap | ₹ 18.55 Cr |
Mono Pharmacare Ltd Technicals
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
Mono Pharmacare Ltd Fundamentals
| ROCE | 3.379 |
| P/E Ratio | 45.000 |
| P/B Ratio | 0.500 |
| Industry P/E | 0.500 |
| Debt to Equity | 51.431 |
| ROE | 1.119 |
| EPS | 0.200 |
| Dividend Yield | 0.000 |
| Book Value | 17.856 |
| Face Value | 10.000 |
Mono Pharmacare Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 |
|---|---|---|---|
| Total Revenue | 85.1765 | 72.4165 | 14.1135 |
| Total Expenses | 81.4033 | 69.5599 | 13.4476 |
| Profit After Tax | 3.0902 | 2.4424 | 0.5418 |
Mono Pharmacare Ltd Shareholding Pattern
| Promoter Holdings | 56.724 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 33.278 % |
| Others - | 9.998 % |
About Mono Pharmacare Ltd
Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s. Mono Chemist' through Partnership Deed dated May 06, 1994. The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad. The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners. Further, Promoters acquired 100% ownership of the partnership firm on July 25, 2019. Accordingly, Company acquired proprietorship firm of the Promoter, Panilam Lakhatariya M/s DLS Export pursuant to Deed of Business Transfer Agreement dated December 15, 2022 and on October 23, 2020 it acquired 99% ownership of Partnership Firms, M/s. Ahmedabad Medical Corporation (AMC) and M/s. Supal Distributors LLP from the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya dated January 10, 2023. In August 2023, ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 45.62 +1.61 (+3.66%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 509.35 -4.9 (-0.95%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,951.50 -155 (-2.18%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 616.75 +28.65 (+4.87%) |
| Abbott India Ltd Pharmaceuticals | ₹ 25,850.00 -325 (-1.24%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,409.20 -14.3 (-1%) |
FAQs on Mono Pharmacare Ltd
1. Can I buy Mono Pharmacare Ltd from PL Capital? ›
2. Does Mono Pharmacare Ltd pay dividends? ›
3. What is the current share price of Mono Pharmacare Ltd ? ›
4. What is the 52-week high and low of Mono Pharmacare Ltd ? ›
Start SIP in Mono Pharmacare Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
